Company intelligence / Profile preview
Rapalogix Health
- Ownership
- Private
- Development stage
- Other
Overview
Rapalogix Health is a private biotechnology company focused on translating longevity science and mTOR biology into dermatology therapeutics and pro-longevity skin health products. The company is developing TORC1-selective compounds intended to address the biological drivers of skin aging and chronic skin disorders rather than only treating surface symptoms. Its lead commercial product is Re-Q Pro-Longevity Face Serum, powered by proprietary molecule RLX-201, and its lead prescription therapeutic candidate is RLX-202, which is in IND-enabling development for aesthetic dermatology and broader dermatologic applications. Rapalogix was spun out to apply Cambrian Bio's TORnado platform to skin health and is building a combined therapeutics-plus-professional-skincare business model. In June 2026, the company announced a $20 million Series A financing to expand Re-Q Health and advance its prescription pipeline.
- Therapeutic areas
- Dermatology
- Modalities
- Small moleculeProfessional skincare product
- Industry
- Biotech
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →Partnerships
Beyond the preview
Go deeper on Rapalogix Health.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Rapalogix Health.